You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

CLINICAL TRIALS PROFILE FOR PIFLUFOLASTAT F-18


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for piflufolastat f-18

Trial ID Title Status Sponsor Phase Start Date Summary
NCT05394259 ↗ A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer Not yet recruiting Lantheus Medical Imaging Early Phase 1 2022-11-30 To learn if piflufolastat F18 can be used in imaging scans for patients with breast cancer, HCC, or pancreatic cancer
NCT05394259 ↗ A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer Not yet recruiting M.D. Anderson Cancer Center Early Phase 1 2022-11-30 To learn if piflufolastat F18 can be used in imaging scans for patients with breast cancer, HCC, or pancreatic cancer
NCT05919329 ↗ Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy Not yet recruiting Oregon Health and Science University Phase 4 2024-05-01 This clinical trial investigates the change in prostate-specific membrane antigen (PSMA) expression in response to hormonal therapy in both, Castration Sensitive Prostate Cancer (CSPC) and Castration Resistant Prostate Cancer (CRPC), and whether this change in PSMA expression changes tumor staging after therapy initiation. Understanding these effects can help define the best timing to perform the PSMA positron emission tomography (PET) relative to the start of therapy.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for piflufolastat f-18

Condition Name

Condition Name for piflufolastat f-18
Intervention Trials
Breast Cancer 1
Castration Resistant Prostate Cancer 1
Castration Sensitive Prostate Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for piflufolastat f-18
Intervention Trials
Prostatic Neoplasms 2
Hypersensitivity 1
Pancreatic Neoplasms 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for piflufolastat f-18

Trials by Country

Trials by Country for piflufolastat f-18
Location Trials
United States 3
Australia 2
Singapore 1
Israel 1
Japan 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for piflufolastat f-18
Location Trials
Virginia 1
Oregon 1
Texas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for piflufolastat f-18

Clinical Trial Phase

Clinical Trial Phase for piflufolastat f-18
Clinical Trial Phase Trials
Phase 4 1
Phase 3 1
Early Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for piflufolastat f-18
Clinical Trial Phase Trials
Not yet recruiting 2
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for piflufolastat f-18

Sponsor Name

Sponsor Name for piflufolastat f-18
Sponsor Trials
M.D. Anderson Cancer Center 1
Oregon Health and Science University 1
Progenics Pharmaceuticals, Inc. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for piflufolastat f-18
Sponsor Trials
Other 3
Industry 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.